The Cytel Blog: Perspectives on Enquiry & Evidence

A number of methods currently exist to measure non-adherence and non-persistence of medical therapies, for improved..

‘Drugs do not work in patients who do not take them,’ said former surgeon general C. Everett Koop. Unfortunately, the..

Recently, Cytel co-founder Professor Cyrus Mehta noted that, “Clinical trial design selection is too much like an art,..

For much of the past three decades, even as methodologies for clinical trial design have advanced and refined, the idea..

There has been an increasing use of digital measures in drug development recently. New wearables technologies can help..

Scientists at Cytel recently published a paper in the Journal of the American Medical Association (JAMA). Among the..

As decentralized clinical trials become more attractive in an era of COVID-19, the role of wearables in clinical..

Former Commissioner of the FDA, Dr. Scott Gottlieb, in several public presentations, would bemoan missed chances to..

The use of wearable and digital technology requires considerations for both drugs and devices regulations, and..